CSL Seqirus

CSL Seqirus is part of CSL Limited (ASX:CSL). As one of the largest influenza vaccine providers globally, CSL Seqirus is a major contributor to global influenza prevention and a cross-continental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., U.K., and Australia, CSL Seqirus boasts leading R&D capabilities and leverages egg-based, cell-based, and adjuvant technologies to deliver a broad portfolio of differentiated influenza vaccines across more than 20 countries worldwide.